Skip to main content
SpringerLink
Log in

Effects of the calcium channel blocker nifedipine on epiphyseal growth plate and bone turnover: A study in rabbit

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

The potential effects of a calcium channel blocker (nifedipine) on epiphyseal growth plate and bone remodeling have been investigated in growing rabbits. The treated group received 6 mg/kg/day nifedipine twice daily by gavage for 10 weeks. An untreated group was used as control; with this dose, neither toxic effects nor decrease in the body weight have been observed. No modifications of blood phosphocalcic parameters have been found. In the treated group there is a significant lower cancellous bone volume, lower osteogenesis, shorter labeled perimeters, and lower mineral apposition rate than in the control group. Epiphyseal growth plate thickness is lower than in the untreated animals and considerable morphological changes are observed in the growth zone compared with the control group. A decrease in the growth of humerus length was found. In conclusion, nifedipine affects bone physiology, especially with consequences on bone growth. These effects appear to be quantitatively important, and there is the possibility of bone side effects on therapeutic use in humans, especially in young subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fleckenstein A (1984) Calcium antagonist: history and prospects for a multifaceted pharmacodynamic principle. In: Opie LH (ed) Calcium antagonists and cardio-vascular disease. Raven Press, New York, pp 9–28

    Google Scholar 

  2. Katz AM, Hager WD, Messineo FC, Pappano AJ (1984) Cellular actions and pharmacology of the calcium blocking drugs. Am J Med 77:2–10

    Google Scholar 

  3. Goligorsky MS, Chaimovitz C, Shany S, Rapoport J, Sharony Y, Haichenco J (1986) Verapamil improves defective duodenal calcium absorption in experimental chronic renal failure. Miner Electrolyte Metab 12:363–370

    Google Scholar 

  4. Hermann-Erlee MP, Gaillard PJ, Hekkelman JW, Nijmeide PJ (1977) The effect of verapamil on the action of parathyroid hormone on embryonic bone in vitro. Eur J Pharmacol 46:51–58

    Google Scholar 

  5. Lerner U, Gustafson T (1982) Inhibition of 1 alpha-hydroxy vitamin D3-stimulated bone resorption in tissue culture by calcium antagonist verapamil. Eur J Clin Invest 12:185–190

    Google Scholar 

  6. Ly SY, Rebut-Bonneton, Miravet L (1985) Effect of the calcium antagonist diltiazem on in vitro and in vivo bone resorption. Horm Metab Res 17:152–155

    Google Scholar 

  7. Goligorsky MS, Chaimovitz C, Rapoport C, Golstein Kol R (1985) Calcium metabolism in uremic nephrocalcinosis: preventive effect of verapamil. Kidney Intern 27:774–779

    Google Scholar 

  8. Duriez J, Flautre B, Blary MC, Duriez R (1990) Effet d'un inhibiteur calcique, le verapamil sur le développement des ossifications hétérotopiques. Etude expérimentale chez le rat. Intern Orthop 14:415–421

    Google Scholar 

  9. Chagnac A, Gazit D, Zahavi I, Sela J, Levi J (1989) Effect of verapamil on bone resorption in uremic rats. Miner Electrolyte Metab 15:291–294

    Google Scholar 

  10. Messler HH, Koch W, Munzenberg KJ (1990) Analogous effects of organic calcium antagonists and magnesium on the epiphyseal growth plate. Clin Orthop 258:135–141

    Google Scholar 

  11. Eguchi M, Shibata K, Wada F, Kawamura H, Shimauchi T, Shiota E, Sugioko Y (1986) The calcium antagonist diltiazem inhibits calcification enhanced by calcitonin in growth cartilage of rats in E.H.D.P.-induced rickets. Acta Endocrinol 113:5–14

    Google Scholar 

  12. Parfitt AM, Drezner, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry standardization of nomenclature symbols and units report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res 2:595–610

    Google Scholar 

  13. Flautre B, Hardouin P (1992) La microradiographie dans les paramètres trabéculaires. Acta Orthop Belg 58:287–296

    Google Scholar 

  14. Meunier PJ (1983) Histomorphometry of the skeleton. In: Peck W (ed) Bone and mineral research annual 1. Excerpta Medica, Amsterdam, pp 191–222

    Google Scholar 

  15. Vedi S, Compston JE, Webb A, Tighe JR (1983) Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of normal British subjects. Metab Bone Dis Rel Res 5:69–74

    Google Scholar 

  16. Krstic RV (1988) Tissu osseux. Ossification indirecte ou chondrale. In: Masson (ed) Atlas d'histologie générale, Paris, pp 202–203

  17. Boesgaard S, Hyldstrup L, Feldstedt M (1991) Changes in calcium homeostasis and bone formation in patients recovering from acute myocardial infarction: effect of verapamil treatment. Danish study group on verapamil in myocardial infarction. Eur J Clin Pharmacol 41:521–523

    Google Scholar 

  18. Sjoden G, Rosenquist M, Kriegholm E, Nordenstrom J, Bjorkhem I (1990) Verapamil increases serum alkaline phosphatase in hypertensive patients. J Intern Med 228:339–342

    Google Scholar 

  19. Murray EJ, Curran D, Deftos LJ, Manolagas SC (1986) Modulation of 1-25(OH)2D3 and glucocorticoid regulation of alkaline phosphatase by calcium channels blockers. J Bone Miner Res 1:67

    Google Scholar 

  20. Bernheim J, Kalinsky Z, Rothaus M, Shapira M (1985) The influence of the calcium channel blocking agent nifedipine on the excretion of parathyroid hormone. In: Ornay A, Harell A, Sela J (eds) Current advances in skeletogenesis. Elsevier Science Publishers, New York, pp 161–164

    Google Scholar 

  21. Seely EW, Leboff MS, Brown EM et al. (1989) The calcium channel blocker diltiazem lowers serum parathyroid levels in vitro and in vivo. J Clin Endocrinol Metab 68:1007–1012

    Google Scholar 

  22. Fox J (1988) Verapamil induces PTH resistance but increases duodenal calcium absorption in rats. Am J Physiol 255:E702–707

    Google Scholar 

  23. Hermann-Erlee MP, Gaillard PJ, Hekkelman JW, Nijweide PJ (1977) The effect of verapamil on the action of parathyroid hormone on embryonic bone in vitro. Eur J Pharmacol 46:51–58

    Google Scholar 

  24. Albers M, Johnson W, Vivian V, Jackson RD (1991) Chronic use of the calcium channel blocker nifedipine has no significant effect on bone metabolism in men. Bone 12:39–42

    Google Scholar 

  25. Kim YS, Yang IM, Kim SW, Kim KW, Choi YK (1991) Responses of osteoblastic cell line MC3T3-E1 to the calcium channel blocker diltiazen and verapamil. Contrib Nephrol 91:43–49

    Google Scholar 

  26. Bert JM, Posalaky Z, Snyder S, McGinley D, Chock C (1990) Effect of various irrigating fluids on the ultrastructure of articular cartilage. Arthroscopy 6:104–111

    Google Scholar 

  27. Zaidi M, MacIntyre I, Datta HK (1990) Intra-cellular calcium in the control of osteoclast function. II. Paradoxal elevation of cytosolic-free calcium by verapamil. Biochem Biophys Res Commun 167:807–812

    Google Scholar 

  28. Dietrich JW, Duffield R (1979) Effects of the calcium antagonist verapamil on in vitro synthesis of skeletal collagen and noncollagen protein. Endocrinology 105:1168–1172

    Google Scholar 

  29. Farah MJ, Palmieri GMA, Sebes JI, Cremer MA, Massie JD, Pinals RS (1990) The effect of diltiazem on calcinosis in a patient with CREST syndrome. Arthritis Rheum 33:1287–1293

    Google Scholar 

  30. Scholz G, Marek H, Grossman KD, Kellner KA, Chenbach H (1989) Verapamil beim primaren hyperparathyroidismus. Z Gesamte Inn Med 44:330–332

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut de Recherche sur les Maladies du Squelette, Institut Calot, 62608, Berck Sur Mer, France

    J. Duriez, B. Flautre, M. C. Blary & P. Hardouin

Authors
  1. J. Duriez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Flautre
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. C. Blary
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Hardouin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duriez, J., Flautre, B., Blary, M.C. et al. Effects of the calcium channel blocker nifedipine on epiphyseal growth plate and bone turnover: A study in rabbit. Calcif Tissue Int 52, 120–124 (1993). https://doi.org/10.1007/BF00308320

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00308320

Key words

Search

Navigation